Sign in
Taking peopleNo phase

The Impact of Low Versus High Positive End-expiratory Pressure on Diaphragm Function, Ventilation Efficiency, and Lung Mechanics

Key facts

Who runs it
Vastra Gotaland Region
Where
Sweden2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
25 people, planned
Started
31 Aug 2026
Expected to end
31 Dec 2027
Type of study
Interventional, 3 groups
Treatments tested
  • Low positive end-expiratory pressure
  • Medium positive end-expiratory pressure
  • High positive end-expiratory pressure
Record updated
2 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Mechanical ventilation with pressure support or mechanical ventilation with possibility to transition to pressure support
  • Oxygen requirement ≤ 50%
  • Pressure support ≤ 12 cmH2O
  • PEEP ≤ 12 cmH2O
  • Age ≥ 18 years
  • Adequate intravascular volume status

Who cannot take part

  • Conditions with increased risk of pneumothorax (such as severe COPD (Chronic Obstructive Pulmonary Disease) or extensive emphysema)
  • Heart rate > 120 beats/min
  • Circulatory instability
  • Brain death diagnosis/brain death evaluation
  • Norepinephrine dose > 0.4 µg/kg/min
  • Muscle relaxation administered within 2 hours
  • Pregnancy
  • Contraindication to esophageal catheterization (e.g., esophageal varices)
  • Untreated pneumothorax
  • Symptomatic airway obstruction; Discontinuation criteria during ongoing study intervention:
  • Systolic blood pressure > 180 mmHg
  • Inspired oxygen fraction > 70%
  • Respiratory rate > 35/min
  • RASS (Richmond Agitation Sedation Scale) ≥ 2
  • Doubling of norepinephrine dose or increase of norepinephrine dose to > 0.5 µg/kg/min to maintain mean arterial pressure
  • Bradycardia < 45 beats/min

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this interventional study is to evaluate the effect of different positive end-expiratory pressures (PEEP) on lung and diaphragm function in patients mechanically ventilated with pressure support ventilation in the intensive care unit. The main questions aim to answer:

Read full original descriptionShow less

Does higher PEEP level affect diaphragm contractions and ventilatory efficiency? Does higher PEEP level limit inspiratory efforts? Does higher PEEP level affect lung compliance?

The participants will be subjected to three different PEEP levels during pressure support ventilation:

Low PEEP (4 cmH2O), Medium PEEP (10 cmH2O), High PEEP (16 cmH2O).

The lung and diaphragm function will be evaluated using high-resolution esophageal manometry, electrical activity of the diaphragm, external diaphragm ultrasound and spirometric ventilator data.

The 3 groups in the trial

  • Low PEEPTreatment being tested

    Low positive end-expiratory pressure (4 cmH2O)

    Treatment: Low positive end-expiratory pressure

  • Medium PEEPTreatment being tested

    Medium positive end-expiratory pressure (10 cmH2O)

    Treatment: Medium positive end-expiratory pressure

  • High PEEPTreatment being tested

    High positive end-expiratory pressure (16 cmH2O)

    Treatment: High positive end-expiratory pressure

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Impact of Low Versus High Positive End-Expiratory Pressure on Diaphragm Function, Ventilation Efficiency, and Lung Mechanics During Pressure Support Ventilation: A Randomized Interventional Crossover Study
Record updated
2 September 2026